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An

striatal LTD is lost following DA denervation and chronic levodopa treatment. It is
possible that
achetylcholine (ACh) and glutamate, which in tum leads to the induction of striatal LTP.
ACh and glutamate may produce these
striosomal pathway in addition to their

in motor behavior by affecting the
on the direct (striatonigral) pathway and the

indirect (striatopallidal) pathway of the basal ganglia. This thesis postulates that by
blocking LTP expression in the DA depleted striatum, that the occurrence of LID will be
reduced. Heterosynaptic plasticity is a mechanism in which long-tem1 facilitation
proceeds in the state of LTD or LTP depending on the levels of intracellular calcium
IV

present Artificial neural networks (ANN) may be used to speculate and predict the most
accurate and precise combinations of levodopa, ACh antagonist and glutamate
antagonists that will achieve the goal of preventing LTP in DA denervated and chronic
levodopa treated biological systems to reduce/eliminate LID.
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CHAPTER 1
INTRODUCTION

Parkinson's disease (PD) is a movement disorder that affects more than half a
million people in the United States (Langer A and Lozano R, 1998). Individuals with PD
experience motor abnormalities as a result of this neurodegenerative disease (Langer A
and Lozano R, 1998). Early motor disturbances are presented as tremors usually in one of
the extremities. As the disease progresses over time, additional motor complications
appear. These motor complications include patients becoming stiff and their actions
become delayed. Some PD patients begin to have trouble initiating movements, losing
coordination or complete lack of mobility. Non-motor symptoms associated with PD such
as mood, sleep and cognitive disturbances are also prevalent but will not be discussed in
paper (Langer A and Lozano R, 1998). The typical onset of PD occurs in patients
between the

of 50-60 (]ellinger

2001). Because some of the initial motor

disturbances are subtle, the diagnosis may not be immediately recognized. As the
neurodegenerative progression builds steadily, PD symptoms become obvious and very
confining for patients who

lived with the disease for an

often years

(Klawans HL, 1996).
The primary brain regions affected in PD are the basal ganglia (Pollack AE,
2001 ). A substantial decrease in the neurotransmitter, dopamine (DA), as is the case in
PD has dramatic effects on the basal ganglia. As a result, the symptoms ofPD are
treatable by pharmaceutical agents (Langer A and Lozano R, 1998). The most commonly
used drug treatment for PD is DA replacement therapy with the most effective drug being
1

levodopa, the chemical precursor to DA (CaJon F. eta!., 2000). Levodopa is absorbed in
the gastrointestinal tract in the small bowel and is rapidly distributed to other tissues with
a half-life of 5-10 minutes (Koller WC, 2000). Levodopa readily crosses the blood brain
barrier whereas exogenously administered DA itself is unable to do so. Although initially
effective, chronic treatment with levodopa results in debilitating side effects such as the
uncontrollable, involuntary movements known as dyskinesias (CaJon F. et al., 2000;
Hirsch E., 2001).
The purpose of this thesis is to present a new hypothesis for the mechanism
underlying levodopa induced dykinesias (LID), which posits that these abnormal,
involuntary movements are the result of disturbances of a memory mechanism in the
basal ganglia that promotes long term changes ultimately leading to LID. Because the
neurotransmitters in the basal ganglia involved in LID and their interactions with one
another arc not clearly defined, an artific1al neural network (ANN) model will be
presented as an appropriate method for assessing these neurotransmitter relationships.
Once developed, the ANN can be trained to prevent these long-term memory changes
from occurring within the model system, thereby potentially uncovering therapeutic
regiments to control LID. In order to understand this hypothesis, an overview of the
anatomy and physiology of the basal ganglia, the brain regions involved in PD, is
presented. This anatomical insight provides a foundation for understanding the cellular
mechanisms in the basal ganglia that arc activated during LID.
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Basal Ganglia Anatomy

The basal ganglia consist of brain regions that serve as a key processing center in
the control of movement as well as the processing of a certain types of motor memory
associated with conditioned responses (Graybiel AM et al., 2000). The basal ganglia
structures are compromised of five extensively interconnected subcortical nuclei in the
forebrain that wrap around the thalamus beneath the anterior portion of the lateral
ventricles (Graybiel AM, 1990). The individual structures are specifically termed:
caudate nucleus, putamen, globus pallidus, subthalamic nucleus and substantia nigra
(Figure 1) (Graybiel AM, 1990). The basal ganglia structures form an intricate network
of parallel loops that integrate and redistribute information from the cortex, and in tum,
project this information to the thalamus that affects the motor cortex in the frontal lobe
(Smith D. et al., 1997).
Information coming into the basal ganglia originates from a variety of locations in
the cerebral cortex, thalamus and the limbic system (Parent A. et a!., 200 l ). This input
enters the basal ganglia in the striatum (Parent A. et al., 2001 ), which is a collective term
for the caudate and putamen (Parent A. ct al., 2001 ). Inputs to the striatum from the
thalamus and cortex are excitatory and usc the neurotransmitter glutamate (Pollack AE,
2001; Smith A. et al., 1998). Other inputs include serotonin from the Raphe nucleus,
achctylcholine (ACh) from striatal intcmeurons and DA from the substantia nigra pars
compacta (SNc) as described below (Pollack AE, 2001).
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Figure 1: (inodifiedfrom MoussaBH and Riederer Youdim and Peter, 1997) Basal
Ganglia Structures: caudate nucleus, putamen, glohus pallidus, suhthalamic nucleus and
suhstantia nigra. Th e pars compacta of the suhstantia nigra loses dopamine neurons
which disturhs motor control in PD. The suhstantia nigra DA neurons fo rm the
nigrostriata/ pathway as they proJect to the striatum. The raph e nuclei which supplies
serotonin to the hasal ganglia loses neurons that produces nonmotor disturhances (e.g.
depression) in PD.
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Once information has reached the striatum it is processed through the basal
ganglia circuitry before exiting the thalamus and brainstem via the basal ganglia output
structures: the globus pallidus (GPi) and the substantia nigra reticulata (SNr) (Starr MS,
1995). The GP is divided into internal (GPi) and external (GPe) segments (Albin RL et
a!., 1998). Similarly, the substantia nigra, which is located in the midbrain, has several
components, the SNr and the SNc (Albin RL et al., 1998). The SNc contains the DA
neurons that project to the striatum and form the nigrostriatal pathway (Smith A. et al.,
1997). It is the DA neurons of the SNc that degenerate in PD.

Basal Ganglia Circuitty

Between the basal ganglia inputs and outputs arc two major pathways of
projection neurons whose cell bodies arc located in the stnatum (Smith A. ct al., 1997).
These arc referred to as the "direct" and ''indirect" pathways. In the current model of
basal ganglia function, all information conveyed through the basal ganglia input
structures is processed withm the basal ganglia and flows out through one of these
pathways to the basal ganglia output structures (Figure 2) (Smith A. eta!., 1997). The
concerted and contrasting effects ofthc "direct" and "indirect" pathways function to
control motor behavior in the basal ganglia by supplying both a break and an accelerator
on the thalamus.
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Figure 2: (modified from Pollack AE, 2001) Basal Ganglia Circuitry: Connections and
Neurochemical Modulators: Glutamate (Glut:excitatOty) connections lead from the
cortex to the striatum, from the STN to the SNr!GPi and from the thalamus to the cortex.
All other connections are inhibitory and utilize gamma-aminohutyric acid (GABA;
inhihitof}).

All the connections within the basal ganglia are inhibitory with the exception of
the projection from STN to SNr/GPi which is excitatory (Figure 2) (Gerfen CR et al.,
1990). The direct pathway consists of a direct inhibitory projection to the SNr/GPi which
allows the inhibition directed to the thalamus from the SNr/GPi to be reduced (Smith A.
et al., 1997). The indirect pathway has an excitatory connection to the GPi/SNr, the STN,
thereby causing greater inhibition to the thalamus (Smith A. et al., 1997). As information
passes through the basal ganglia and becomes modified, this information projects to three
thalamic nuclei: the ventral lateral, the ventral anterior and the mediodorsal (Smith A. et
al., 1997). These thalamic nuclei then projects to the prefrontal cortex, the premotor
6

cortex (PMC), the supplementary motor area (SMA) and the primary motor cortex (Smith
A. et al., 1997). The SMA is a major input to the basal ganglia and therefore creates a
loop between the SMA and the basal ganglia (Smith A. et al., 1997). The SMA is
involved with planning sequences of movement (Smith A. et al., 1997). Without the
thalamus receiving information from the basal ganglia and conveying this information
back to the cortex, the cortex would not be able to properly direct voluntary motor control
(Gerfen CR, 1990). This Cortico-Basal Ganglia-Loop is maintained by two
neurotransmitters: glutamate (excitatory) and gamma-amino butyric acid (GABA)
(iuhibitory) (Figure 3) (Rascol 0. et al., 2001).
DA that is
pathway

through D 1 receptors and inhibitory ette~cts on the indirect pathway

acting through D2 receptors (Rascol 0. et al., 2001).
direct and indirect

striatal projection neurons in

comprise 90-95% of the neuronal populations of the

striatum and are medium spiny neurons that contain the iuhibitory neurotransmitter
GABA. The one

connection in the basal

from the STN to the SNr/GPi,

uses glutamate as its excitatory neurotransmitter (Gerfen CR, 1990). Input from the
cortex to the striatum is also excitatory and uses glutamate as its neurotransmitter ( Gerfen
CR, 1990).
Five different types ofDA receptors have been cloned (Parent A. et aL, 2001). Dl
like receptors (D 1 and D5) stimulate intracellular adenosine 3 '5 '-eye lie phosphate
(cAMP) production, whereas D2 like receptors (D2-D4) iuhibit cAMP production
(Gerfen et at. 1990). Primarily Dl and D2 receptors are located on the shafts of dendritic
spines of GABA containing striatal projection neurons (Pollack AE, 2001 ).
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Figure 3: (modified from Carlson NR, 2001) The Cortico-Basal Ganglia Loop. The
connections of the excitatory Dl receptor activity and inhibitory D2 receptor activity are
shown. The cortico-basal ganglia motor loop, maintained by information about planned
movements executed by the primary motor cortex (PMC) and the primary somatosensory
cortex (PSC). Inputs from the PMC and PSC project to the putamen. The signal then
proceeds to the caudate and globus pallidus and returns back to the motor cortex via the
ventrolateral thalamus. The loop is completed when the information from the PMC and
PSC are sent to the putamen.
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Excitatory glutamatergic inputs synapse on the heads of these same dendritic spines
(Pollack AE, 2001). It has been proposed that due to their close proximity and anatomical
arrangement, that DA synaptic activity may modulate glutamatergic input on these
medium spiny neurons (Pollack AE, 2001).
Approximately 1-2% of the neuronal population in the striatum are the large ,
aspiny interneurons with extensive collaterals that use ACh as a neurotransmitter (Starr
MS, 1995). Three different types of ACh muscarinic receptors are found in the striatum:
M1, M2 aand M4 (Blanchet F. et al., 1997; Pollack AE, 2001). Ml and M4 muscarinic
receptors are located on both cholinergic interneurons as well as on medium spiny
neurons (Pollack AE, 2001). M2 muscarinic receptors are located on cholinergic
interneurons as are 02 & D5 receptors and to a much smaller degree D 1 receptors
(Blanchet F. et al., 1997; Pollack AE, 2001 ). ACh synapses have been found on the
dendritic spines and cell bodies of medium spiny neurons (Pollack AE, 2001 ). These
ACh interneurons, as well as medium spiny neurons, also express ionotropic glutamate
receptors, N-methyl-D-aspartate (NMDA) receptors and Alpha-amino-3-hydroxy-5methyl-4-isoxazole-propionic acid (AMP A) receptors.
Recent evidence suggests that muscarinic receptor activation has a role in
stabilizing the physiological states of striatal neurons (Suzuki T. et al., 1998). Calabresi
P. et al. (1999) described striatal neurons a having two physiological states denoted as
"down" and "up." A "down" state describes a neuron that is hyperpolarized and an "up"
state describes a depolarized striatal neuron (Calabresi P. et al., 1999). In this thesis, the
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physiological states of striatal neurons will be referred to as hyperpolarized and
depolarized. Normally, the striatal neurons show very little excitability due to the large
number of potassium channels that oppose the influx of calcium (Nisenbaum ES et al.,
1996). Therefore, the typical state for a striatal neuron is hyperpolarized (Calabresi P. et
al., 1999). Following DA denervation, there is a rise in the excitatory neurotransmitter
glutamate in the striatum and striatal neurons spend less time in their hyperpolarized state
and enter an oscillating state where the neurons frequently shift from a hyperpolarized
state to a depolarized state (Calabresi P. et al., 1997). Since these oscillatory striatal states
are unable to be reproduced in vitro this suggests that an intact corticostriatal system is
necessary to induce this oscillatory behavior (Calabresi P. et al., 1990). NMDA and
AMPA glutamate receptors located on medium spiny neurons are also differentially
activated in the striatum depending upon which physiological state the striatal neurons
are in (Calabresi P. et al, 1997). The striatal depolarized state is correlated with NMDA
receptor activation, whereas the striatal hyperpolarized state is correlated with AMPA
receptor activation (Calabresi P. et al., 1997). ACh has also been found to enhance the
NMDA mediated responses recorded from medium spiny cells in the striatum (Guebellini
et al., 1998), suggesting a possible role of ACh in inducing a long lasting elevation of
corticostriatal glutamatergic transmission (Guebellini P. et al., 1998). The increase of
ACh in the striatum, elevates NMDA receptor activation on striatal medium spiny
neurons, in turn, enlargens the influx of calcium in the striatal medium spiny neurons.
Thus, ACh in the striatum has a role in controlling intracellular levels of calcium in
medium spiny neurons. Therefore, ACh in striatal interneurons serves a significant role in
modulating chemical activity in this brain region.
10

DA has a differential effect on the activity of ACh interneurons depending upon
which DA receptors are activated (Blanchet F. et al., 1997). For example D 1 receptors
facilitate the release of ACh whereas D2 receptors inhibit ACh release (Blanchet F. et al.,
1997). Differential effects on behavior in DA receptor deficient mice have also been
noted, with D2 receptor deficient mice expressing behaviors that resemble Parkinsonian
symptoms, whereas D 1 receptor deficient mice do not (Baik JH et al., 1995; Drago J. et
al., 1994). Since D2 receptors inhibit ACh release, the question arises in the D2 receptor
deficient mice if it is the absence ofD2 receptors that affects motor behavior directly or
whether it is through an indirect effect of D2 receptors on cholinergic interneurons. It is
important to understand if ACh or DA has a more dominant role in affecting motor
behavior because such insight may provide a better therapeutic regiment for PD.
Taken together, ACh has two significant roles in the striatum. ACh interneurons
appear to have a modulatory role in stabilizing the physiological states of striatal neurons
and they also have a role in regulating NMDA responses on medium spiny neurons
(Guebellini P. et al., 1998). The role of ACh in the striatum is one that is central to the
physiology of the basal ganglia and therefore may be intimately involved in the onset of
LID.

Striatum: Matrix and Striosomes

The striatum, based upon its neurochemical design, has been separated into two
fundamental compartments: the matrix and the striosomes (Graybiel AM et al., 2000).
Most of past and current PD research has only considered the role of the matrix
ll

compartments, where the cell bodies from the direct and indirect pathways are located,
for exploring LID (Graybiel AM et al., 2001). The striosomes are surrounded by the
larger matrix and its cells project to the dopamine containing neurons of the SNc (Figure
4). Interestingly, neurons in the striosomes compartment are naturally activated by

pulsatile stimulation ofDA receptors in response to new stimuli in the environment
(Graybiel AM et al., 2000). But, exploration ofhow striosomes affect the cells of the
matrix has been only marginally investigated (Graybiel AM et al., 2000). Therefore,
investigating the influence of the striosome compartment on the matrix neurons could
lead to a new understanding of the underlying mechanisms in LID.
The matrix and striosome compartments have distinct afferent and efferent
connections (Dure LS IV et al., 1992): The striosomes receive inputs from the prefrontal
cortex, the insular cortex and the amygdala and the matrix receives its major input from
the association and sensorimotor cortex (Dure LS [V et al., 1992). Striatal circuitry
differs for efferent connections from each compartment as well; striosomal neurons
project primarily to the SNc whereas the matrix neurons project to the GPe, GPi and SNr.
Ligand binding for the D 1 receptor subtype is more pronounced in the striosomes as is
acetylcholinesterase histochemistry. Conversely, D2 receptor binding and
immunostaming for tyrosine hydroxlase are more concentrated in the matrix (Graybiel
AM and Langer LF, 1989). Therefore, D 1 receptors and ACh are more prominent in the
striosomes compared to D2 receptors which are contained in the matrix.
The potential influence of the striosomal pathway on the basal ganglia has largely
been overlooked, but it may hold significance since this pathway is in a position to
regulate input to the striatum. This is a key point because the activity of the striosomal
12

pathway could have a direct effect on motor behavior because the projections from the
striosomal pathway reach the SNc where they could influence the DA projection back to
the striatum (Graybiel AM et al., 2000). To date, major theories ofPD and LID take into
account only the direct and indirect pathways that primarily comprise the matrix
compartment ofthe striatum without considering the possible effects of the striosomal
pathway on LID.

e

Motor
output

Figure 4. (modified from Graybiel AM et al., 2000) n1ree Pathway Model in the Basal
Ganglia: The striosomal pathway: through the striosomal compartment of the striatum to
the SNc. The direct pathway: through the matrix compartment of the striatum to the GPi
& SNr and then to the thalamus and neocortex. The indirect pathway: through the rnatrix
compartment of the striatum to the GPe, then to the STN, and to the GPi & SNr and then
to the thalamus and neocortex. The nigrostriatal pathway that leads from the SNc to the
striatum which degenerates in PD is also depicted.
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However, because the DA pathway of the SNc is destroyed in PD, there must be
another means for the striosomes to interact with the matrix after the onset of PD. One
candidate serving as a link between the striosome and matrix compartments is the ACh
interneuron. Even though cell bodies of the ACh interneurons are primarily located in the
matrix compartment, their extensive neurites innervate both the matrix and the striosomes
of the striatum (Calabresi P. et al., 1998). In addition, the density of ACh intemeurons is
about twice a high in regions where the matrix borders the striosomes (Blanchet F. et al.,
that ACh interneurons are in the position to
serve a role in transferring information from one striatal compartment to another.
Therefore, it is plausible that ACh interneurons may serve as a communicator between
the striosomal pathway and medium spiny neurons that comprise the matrix (Figure 5).
In the intact basal ganglia, another way for the matrix and striosomes to interact is
through the SNc. The striosomal pathway extends from the striosomes in the striatum to
the SNc and is activated with pulsatile DA treatments. The neurons from the SNc then
project to the matrix in the striatum through the nigrostriatal pathway, thus the activation
of the striosomal pathway could enhance the activation ofthe nigrostriatal pathway and
influence the matrix of the striatum. However, in DA denervated SNc that characterizes
PD, this arrangement seems less likely.

14
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Figure 5: (modified from Blanchet F et al., 1997)ACh borders the Matrix and
Striosomes in the 5'triatum. Striosomes (S] and matrix (iVfx:) compartments are separated
by ACh interneurons which may serve as a communicator between compartments. Both
compartments have GABA projection neurons. The striosomes are comprised of mainlv
D 1 DA receptors that facilitate cAMP activation and the matrix has both D l DA (direct
pathway) and D2 DA (indirect pathway) receptors. The striosomes could influence the
matrixfollowing levodopa treatment by acting via the ACh intcrneurons and affecting the
medium spiny neurons (that contain NMDA and AMPA receptors) of the matrix.
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CHAPTER2
BASAL GANGLIA RESEARCH: MEMORY AND MOTOR STUDIES HAVE
BEEN KEPT SEPARATE

ACh has been recognized as an important molecule in learning and memory
(Calabresi P. et al., 1998). Since the striatum has the highest concentration of ACh found
in the brain, it seems likely that the basal ganglia are an area where ACh may be
positioned to secure new memories (Calabresi P. et al., 1998). In the past, basal ganglia
research has traditionally maintained two separate tracks of scientific investigation
(Graybiel AM et al., 1998). One track has been focused on the role ofbasal ganglia in
learning and memory, and the other track pertains to the role of the basal ganglia in the
control of movement (Graybiel AM, 1998). However, minimal research has focused on
the potential connection between these two tracks. The current explanations of UD as a
purely motor abnormality are evident in this separation of research tracks because there is
minimal investigation into the possibility that alterations in long-term memory patterns in
the basal ganglia underlie the origin of LID. The next section will discuss each of the two
research tracks, the roles of the basal ganglia in learning and memory and the control of
movement, first separately and then in the context of an argument for the relationship
between the two. It may be that the relationship between learning and memory and motor
behavior could convey new insights into PD treatments and LID.

16

Basal Ganglia and Motor Control: The Current Model of PD and LID

The role of the basal ganglia in motor control has largely been viewed from a
clinical standpoint. Much research has been focused on how to understand and therefore
treat motor disturbances of the basal ganglia. PO is the most common motor disorder that
affects these brain structures (Jellinger KA, 2001 ). The motor dysfunction observed in
PO is the result of a decrease in DA in the SNc. These DA neurons normally project from
the SNc to the striatum forming the nigrostriatal pathway (Pollack AE, 2001). Although a
small percentage of DA neurons naturally die off as part of the aging process, the DA
levels in PO are reduced to 30% of their normal concentration ( 5-l OnM) in the striatum
(CaJon F. et al., 2000; Yahr MD, 1993). The reduction in DA in the striatum, in turn,
decreases the activity in the direct pathway and increases the activity in the indirect
pathway (Graybiel AM et al., 2001 ). Since the direct pathway has an inhibitory effect on
the basal ganglia output, SNr/GPi, therefore more inhibition directed to the thalamus
(Figure 2). In contrast the indirect pathway has an excitatory connection to the GPi/SNr
via the STN (Gerfen CR et al., 1990). The loss of DA in the indirect pathway results in
less inhibition on the STN which leads to more excitation to the GPi/SNr output
structures and greater inhibition on the thalamus (Gerfen CR et al., 1990). Since the basal
ganglia output, GPi/SNr, has an inhibitory connection to the thalamus, changes in the
activity of both direct and indirect pathways as a result of DA depletion, produces further
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inhibition of the thalamus which, in tum, decreases thalamic excitation of the motor areas
of the cortex (Gerfen CR et al., 1990). This results in a decrease in motor activity.
The most commonly used symptomatic medical treatment for PD is levodopa, the
chemical precursor to DA, which after years of treatment often results in the disabling
side effects of uncontrollable, involuntary movements known as UD (Caton

et al.,

2000). Existing theories on the manifestation of LID have been based upon clinical
observations of PD patients as well as on animal models of PD. One theory of UD is
based upon experiments that used an animal model of PD in which monkeys were treated
with 1-methyl-4-phenyl-l ,2,5,6-tetrahydropyridine (MPTP) and then given chronic
levodopa treatment. The results indicated that the abnormal movements observed after
chronic treatment with Ievodopa were a result of the reduced activity in the GPi/SNr
(Obeso JA and Okanow CW, 2000). Levodopa treatment was thought to cause too much
inhibition of the projections from the striatum to the GPe neurons, which result in
excessive inhibition of the STN, which, in tum, reduces the excitatory input to the
GPi/SNr (Obeso JA and Okanow CW, 2000). The reduced activity ofthe GABA neurons
in the GPi disinhibits the thalamus resulting in an increase in the activity of the
thalamocortical inputs (Obeso JA and Okanow CW, 2000). This increase in
thalamocortical inputs could result in LID because amplified inputs promoting movement
would be sent from the thalamus to the cortex (Obeso JA and Okanow CW, 2000).
However, this theory is flawed because when the GPi is lesioned it improves UD and PD
motor functions suggesting that a decrease in GPi activity does not account for LID
(Calabresi P. et al., 2000).
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A second theory of LID suggests that it is due to the overactivity of the STN and
that treating with glutamatergic antagonists will relieve the LID because of the potential
of these antagonists to inhibit the excitatory effects of the STN on the output structures,
GPi/SNr (Wichmann T. et al., 1994). However, because the effect of systemically
administered glutamate antagonists is not localized to one specific region of the basal
ganglia, these glutamate antagonists could be working to inhibit glutamate receptors
involved in memory formation and not on the glutamatergic pathway from the STN to the
GPi/SNr. In fact, motor fluctuations have been found to be dramatically reduced in 60HDA lesioned , levodopa treated rats when injected intrastriatally with the NMDA
antagonist, MK801 (Calabresi P. et aL 2000). This suggests the glutamate activity
responsible for motor fluctuations is localized in the striatum.
A third hypothesis for a mechanism underlying LID, the subject of this thesis
posits that the pulsatile administration oflevodopa in the DA depleted striatum interacts
with ACh and glutamate and produces a change in the amount of calcium influx into
striatal medium spiny neurons, which in tum, intensifies the strengthening of synapses on
medium spiny neurons. This synaptic change may activate pathways and cellular
mechanisms similar to those involved in forming long term memories in the basal
ganglia. This thesis examines the possibility that LID are a manifestation of a long term
memory pattern via synaptic mechanisms that occur during learning and memory in the
basal ganglia. Such mechanisms are hypothesized to be induced by DA denervation and
subsequent chronic levodopa treatment that, in turn, leads to the abnormal motor behavior
that characterizes LID.
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Cortex

Figure 6: (modified from Obeso JA and Olanow CW, 2000) Connection Differences in
Nonnal, PD and LID Basal Ganglia. A) normal, B) PD and C) LID basal ganglia can be
seen in the diagram.
of lines and arrow heads indicate amounts of activity. Bold
lines represent an increase in activity, thinner and smaller arrow heads indicate a
reduction in activity.

What has been clearly realized is that the development of LID depends on two
main factors: pulsatile administration of DA replacement therapy and the degree of DA
denervation (Hirsch E, 2001 ). Studies comparing intermittent levodopa administration to
continuous DA administration showed LID does not arise with continuous levodopa
administration (Calabresi P. et al., 2000). Continuous pharmacological stimulation ofDA
receptors results in desensitization of motor behavior whereas intermittent stimulation of
these receptors produces increased sensitization of motor behavior (Calabresi P. et al.,
2000). When rats are administered the DA agonist, apomorphine, their locomotive
responses differ depending upon how the apomorphine is administered (Castro R. et al.,
1985). Castro R. et al. ( 1985) compared DA denervated rats receiving continuous
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administration of apomorphine and noted the locomotive responses increases after
intermittent injections as opposed to continuous administration. In contrast, the
locomotive effect of apomorphine declines when the following injection is given before
the preceding dose is completely metabolized. In addition, the greater the DA depletion,
the larger the motor response to DA pulsatile administration (Castro R. et al., 1985).
Speculations on why this may be are presented below.
Early studies of neuronal activity in the SNc noted a slow and steady firing rate of
DA neurons which serve to produce stable movements (De Long R. et al., 1983). This
observation suggests that the SNc exerts a tonic (i.e. continuous) influence on basal
ganglia circuits (Obeso JA and Olanow CW, 2000). Under normal circumstances in the
intact striatum, DA receptors on striatal neurons are at a basal level of continuous
activation (Calabresi P. et al., 2000). In the DA depleted system ofPD, the synaptic
terminals that store and regulate the release of DA grow dependent upon the peripheral
supply of exogenously administered levodopa (Caton F. et al., 2000). With increasing
loss ofDA in advancing PD, there is a dramatic loss of DA terminals as well as greater
difficulty in buffering the fluctuations in plasma levels of levodopa (Obeso JA and
Olanow CW, 2000). In such instances, fluctuations in the plasma concentrations of
levodopa may expose DA receptors to alternating high and low concentrations ofDA,
therefore disrupting the continuous activation ofDA receptors observed in a normal
system (Obeso JA and Olanow CW, 2000). However, because levodopa has a short half
life in circulation it must be administered in a chronic intermittent fashion (Figure 7)
(Graybiel et al., 2000).

21

Pulsatile stimulation ofDA receptors in the striatum has clearly been implicated
in the onset of LID, however, the exact mechanism underlying LID remains unclear
(Obeso JA and Olanow CW, 2000). What is known is that DA concentration in the intact
nigrostriatal pathway, is at a constant level and is maintained with little variation (Calon
F. et al., 2000).

Dopamine/

CENTRAL

PERIPHERAL

Figure 7: (modified from Koller WC, 2000) Levodopa and absorption in the PNS and
CNS. Central nervous system relies on the periphery for DA supply. The diagram depicts
levodopa being administered in the periphery and transformed into DA once it crosses
the blood brain barrier (BBB) and enters the central nervous system.

Therefore, pulsatile administration oflevodopa contrasts dramatically with this
continuous flow ofDA in the intact striatum. However, recent studies have suggested a
link between the onset of LID and activation of the striosomes in the striatum (Graybiel
AM et al., 2001 ). Past research has shown that the striosomes are involved in the
processing of long-term memory of reinforcement/stimulus response and reward learning
(Graybiel AM, 2000). In fact, pulsatile release ofDA and subsequent DA receptor
stimulation in the striosomes occurs naturally during theses types of learning in the basal
ganglia (Graybiel AM, 2000). Therefore, the pulsatile stimulation induced by levodopa
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treatment for PD may activate the same region in the basal ganglia involved in
reinforcement and stimulus/response learning, the striosomes, and subsequently affect the
activity of the medium spiny neurons of the matrix. A closer look into how the
reinforcement and stimulus/response mechanisms function in the basal ganglia may shed
some insight into what may be occurring during repeated levodopa treatments and
subsequent LID in PD.

Basal Ganglia in Learning and Memmy

In recent decades investigation of the basal ganglia has become an active area of
research in the study of learning and memory (Compton, 2001 ). For example, studies
have substantial evidence that supports the claim that the basal ganglia plays a significant
role in the formation of habits and in stimulus/response learning (Compton DM et al.,
2001 ). Researchers have found that the basal ganglia provide a pathway, the striosomal
pathway, that allows the coupling of sensory information/stimuli with a conditioned
motor behavior (Calabresi P. et al., 1997). Inputs to the striosomes are primarily routed
from the prefrontal cortex, insular cortex and the amygdala (Dure LS IV et al., 1992).
These same regions are important in processing memory (Dure LS IV et al., 1992). An
example of stimulus/response and habitual learning was provided by Pavlov's classical
conditioning experiments which was the first model of learning studied in psychology
(Mackintosh, 2003 ). Pavlov trained dogs to salivate at the sound of a bell by forming a
reflexive behavior to a newly learned association. During the training period a bell
became the "conditioned" stimulus for the dogs following repetitive trials of food
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rewards after the bell was sounded (Mackintosh NS, 2003). A newly learned association
was expressed by behavior. Similarly, the reinforced behaviors on a cellular level appear
to be processed in the striosomes (Graybiel AM et al., 2000). After Pavlov, some of the
earliest work in stimulus/response learning was done by Divac I. (1967, 1968) who
showed that lesions in various parts of the caudate nucleus in rats, monkeys and cats
impaired memory retention. In attempts to train rats to respond by lever presses by using
light as the stimulus and food as a reward for pressing, rats with caudoputamen lesions
were unable to retain this information (Divac I., 1967). Such findings are consistent with
memory consolidation for stimulus/response learning occurring in the striatum which
supports the idea that learned stimulus/response information is held in a labile state and
may be influenced for a brief period following its initial acquisition (McGaugh JL and
Herz MJ, 1972). These observations led to the belief that some functions of the caudate
(striatum) cannot be explained by mere sensory and motor systems alone but rather that
memory was involved for learned motor behavior (Packard, MG. et al., 1989). White NM
et al. ( 1996) presented evidence that the dopaminergic nigrostriatal pathway was involved
in the consolidation of memories. In addition, Divac I. (1968) showed that posttraining
injections ofDA agonists into selective regions ofthe caudoputamen increased retention
of memory tasks. Such work is suggestive that DA in the caudoputamen is necessary in
forming conditioned responses through reinforcement. In fact, distinct parts of the
caudoputamen may differ in their memory-related functions (Graybiel AM, 1995). The
medial part of the caudoputamen has been associated with conditioned reward responses
and the lateral part is correlated with stimulus/response learning (Graybiel AM, I 995 ).
Thus, distinct regions of the striatum are associated with different learning processes.
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Similar to stimulus/response learning is the concept of conditioned reward
responses in the basal ganglia. Anticipation of conditioned rewards as a form of memory
was studied by Schultz W. et al. (1997) in the DA neurons ofthe nigrostriatal pathway.
The reward pathway is activated by DA pulsatile stimulation. Once this DA pulsatile
activation has begun, the brain is prepared to receive novel stimuli. TheDA neurons were
activated by unanticipated reward stimuli compared to conditioned stimuli where rewards
were expected. In the cases where rewards were expected the DA neurons were not
activated. Assessment of reward stimuli is proposed to work by the activation of phasic,
that is, pulsatile, not continuous, DA activity (Schultz W., 1997). Therefore, the initiation
of this phasic DA activity would indicate novel reward stimuli and errors with respect to
the normal/conditioned reward responses. These prediction errors would be translated as
new situations leading to rewards that would require the learning of a novel stimulus
(Schultz W., 1997). DA would be released in response to this new stimulus and serve to
reinforce and consolidate it (Figure 8) (Schultz W., 1997). Such activity is similar to what
occurs in LID which is also a manifestation of pulsatile DA activation in the basal
ganglia. Recent research presents evidence that the striatum is differentially activated
dependent upon the learning of new or familiar behavioral routines (Graybiel AM, 1995).
Studies that support the differential activation of the striatum found that novel behavior/
new learning takes place in the anterior striatum (i.e. caudate nucleus), whereas prelearned or repetitive tasks activate the posterior striatal regions (i.e. putamen). Based on
these data, it is clear that the basal ganglia seem to have a strong role in forming types of
memory involved in conditioned responses. In order to understand how these memories.
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could be formed on a cellular level, it is helpful to review some current theories on the
molecular basis of forms of memory mechanisms
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Figure 8: (modified from Graybiel AM, !995). Learning and Erpression of Behavioral
Routines Flow Chart. A) Information inputs from the prefrontal cortex, limbic system and
SNc are processed through the striatum. Processing through pallidonigral-subthalamic
circuit1y differentiallv activates programs that are sent to the cerebral cortex and to
pattern generators in the brain stem/spinal cord. As time progresses these programs
build behavioral routines. Pale squares in the striatum indicate striosomes, which are
more prominent in the caudate nucleus.
B) Once behavioral programs are learned, their behavioral sequences are ready to be
expressed. Information about action plans are sent from the premotor/motor cortex and
other inputs are sent from the parietal cortex which supplies sensorirnotorlspatial
information which is then processed in the striatum (putamen and parts of the caudate
nucleus). This activates selected programs through the pallidonigral-su.bthalamic
circuitry which are sent to the cerebral cortex and to the brain stem/spinal cord. This
system interacts with the learning system and is modifiable dependent upon evaluation
signals that may be received by the SNc. The dark square in the striatum represents the
striosomal organization of the putamen and caudate nucleus.
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CHAPTER3
HETEROSYNAPTIC PLASTICITY IN THE STRIATUM

Synaptic plasticity is a long lasting change in the functional efficacy of synaptic
transmission that is prompted by certain patterns of brain stimulation (Calabresi P.et al.,
2000). Long term memory has been hypothesized to be a function of this synaptic
plasticity (Silva MA et al., 1997). Therefore, synaptic plasticity occurring in the striatum
may be modulated by the basal ganglia (Calabresi P. et al., 1996). In the most general
terms, synaptic plasticity can be broken down into two basic components, homosynaptic
plasticity and heterosynapic plasticity (Blais BS et al., 1999). Homosynaptic plasticity
involves a single synapse, which with repeated activation either becomes stronger or
weaker (Blais BS et al., 1999). In heterosynaptic plasticity, activity in one neuron
modulates activity in another by either increasing or decreasing its presynaptic strength
(Blais BS et al., 1999). The presynaptic strength would be increased if action potentials
are positively correlated with the postsynaptic cell activity and decreased if the action
potentials are not correlated with the postsynaptic cell activity. The basic idea in
heterosynaptic plasticity is that the synaptic strength of one neuron is modified by the
activity in another neuron (Houk JC, 1995).
In the basal ganglia, heterosynaptic plasticity could be demonstrated by the
striosomal projection neurons possibly affecting the activity of the matrix neurons at
several potential locations. The most probable of these sites is through the ACh
intemeurons that line the border between the matrix and striosomes.
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As stated earlier, the striatal output neurons comprise two distinct compartments,
the striosomes and matrix, with ACh intemeurons located at the striosome/matrix border
(Graybiel AM et al., 2000).This anatomical arrangement may allow the striosomes to
influence, via ACh intemeurons, the projection neurons in the matrix that comprise the
direct and indirect pathways. This synaptic organization illustrates on a cellular level how
reinforcement by heteroynaptic plasticity might work (Houk JC, 1995).
While DA has been associated with positive reinforcement, such memory
mechanisms contributing to LID have been marginally investigated. Positive
reinforcement could activate a heterosynaptic plasticity mechanism in the basal ganglia.
In principle heterosynaptic plasticity combines three factors: presynaptic activity,
postsynaptic activity and a neurochemical reinforcement (Houk JC, 1995). A
neurochemical reinforcement refers to the release of a chemical agent during the
reinforcing activity. Such neurochemical reinforcement has been attributed to
monoamines, such as DA (Calabresi P. et al., 2000). Studies have demonstrated that the
release of monoamine neurotransmitters from one group of neurons can influence long
term changes in transmission efficiency in another group of neurons, even if the
neurotransmitter used in the both pathways are not the same (Houk JC, 1995). For
instance DA in one pathway could influence glutamate cell activity in another pathway.
In generaL heterosynaptic plasticity is facilitated by a monamine mediated increase of the
intracellular concentrations of cAMP (Houk JC, 1995). For example, Frey U. et al. (1993)
found that a brief application of a cAMP analog induces a long lasting potentiation in the
neurons of the striatum. Activation of D 1 receptors which promotes an increase in cAMP
may be responsible for heterosynaptic long term changes in synaptic efficacy of medium
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spiny neurons in the striatum (Houk JC, 1995). Bouyer 11 et al. ( 1984) found that striatal
afferents from the cerebral cortex and DA afferents from the SNc often terminate in close
proximity to one another, their synapses are often on the same dendrites and/or on the
same dendritic spines. Tyrosine hydroxylase (TH) staining showed that these DA
synapses found on dendrites and spines were located on the striatal medium spiny
neurons (Freund TF et al., 1984). Thus, the convergence of dopaminergic, glutamatergic
and cholinergic synapses on medium spiny neurons includes the criterion for
heterosynaptic modification. Following DA denervation, levodopa administered in a
pulsatile manner could possibly activate the striosomes, thereby disrupting the normal
synaptic mechanism in the striatum (Graybiel AM, 2000). In tum, the striosomal
compartment could influence the medium spiny neurons of the matrix by acting through
the ACh intemeurons. The potential influence of the striosomes on the matrix via the
ACh intemeurons would incorporate factors necessary to form heterosynaptic plasticity
resulting in the production of long term memory.

LTP and LTD in the Striatum

The heterosynaptic arrangement of striosomes, ACh and the matrix in the striatum
allows for a bimodal (i.e., weak or strong) stimulation mechanism to change synaptic
efficacy. The two most fundamental molecular theories oflong term memory formation
are long term potentiation (LTP) and long tenn depression (LTD). LTP is an increase in
synaptic strength whereas LTD is a reduction in synaptic strength (Baudry M. et al.,
1993 ). Research suggests there are no synapses exclusively expressing LTP or LTD,
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instead, plasticity in synapses is evoked by either strong stimulation in the case of LTP or
weak stimulation in the case ofLTD (Calabresi P. et al., 1996). Such stimulation would
proceed upwards (L TP) or downwards (LTD) in an extended continuum (Calabresi P. et
al., 1996; Linden DJ, 1998; Zucker RS et al., 1989). On a molecular level, stimulation
intensity determines the amount of calcium influx, which in tum, determines whether
LTP or LTD is triggered (Figure 9) (Zucker RS et al., 2001 ). Therefore, the amount of
intracellular calcium determines the bimodal state ofheterosynaptic plasticity: a lesser
amount of calcium influx triggers LTD whereas a more substantial amount of calcium
influx triggers LTP (Bailey CH et al., 2000). This mechanism may allow for memory
storage to be organized in an array of synaptic weights of different strengths. Synaptic
connections may be driven to their minimal (LTD) and maximum (L TP) strengths within
the neural array and may function to contribute to the regulation of synaptic plasticity by
determining the synaptic connections to present the state of LTP or LTD based upon the
amount of calcium influx (Berke JD and Hyman SE, 2000). Both LTD and LTP
mechanisms have the potential to be expressed in the striatum because of the low
excitability of striatal neurons. However, the normal synaptic mechanism in the striatum
favors LTD, with LTP rarely expressed (Calabresi P. et al., 1997; Hirsch E, 2001). LTD
and LTP both requires activation of striatal glutamate and DA receptors (Calabresi P. et
al., 1994). LTD is triggered in striatal neurons when DA receptors are activated in
addition to AMPA receptor activation, while LTP is triggered when DA agonist
administration is accompanied by NMDA glutamate receptor activation. This may be due
to NMDA receptor's influence on calcium influx.
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Figure 9: (modifiedfrom Bailey CH eta!., 2000) Homosynaptic and Heterosynaptic
Mechanisms. A) homosynaptic: synaptic strengthening occur at the same synapse as it is
being strengthened. B) heterosynaptic: synaptic strengthening between a presynaptic and
postsynaptic cell results as a third neuron, a modulatory interneuron, regulates the
strength of the synaptic strength

The state of synaptic plasticity, LTD or LTP, depends upon the amount of
intracellular calcium in the striatum (Calabresi P. et al., 1994). AMPA and NMDA
glutamate receptors appear linked to LTD and LTP, respectively. Therefore, it may be
useful to analyze these glutamate receptors and assess what specifically in their
individual structure determines these distinct functions to promote LTD or LTP.
Castellani GC et al. (200 1) addressed these questions by the examination of subunit
characteristics of AMPA and NMDA glutamate receptors. Previous studies had provided
evidence supporting the idea that calcium concentration determines the state of synaptic
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plasticity, LTD or LTP (Calabresi P. et al., 1994; Carrol FI et al., 1999). Studies have
confirmed that high frequency stimulation (HFS) of presynaptic afferents leads to LTP
whereas low frequency stimulation (LFS) of presynaptic afferents leads to LTD
(Castellani GC et al., 2001). It has been suggested that subunits of AMPA receptors
directly influence the amount of calcium influx and therefore serve as a regulating
component ofthee bimodality of synaptic plasticity, LTD or LTP (Carrol FI et al., 1999).
AMPA receptors are composed of subunits termed GluR1-GluR4 (Castellani GC et al.,
2001). Properties of AMPA receptors are dependent upon the composition of individual
GluR l-GluR4 subunits and the phosphorylation/dephosphorylation state of the subunit
proteins (Castellani GC et al., 2001 ). Specific sites on these AMPA subunit proteins have
been linked to synaptic plasticity, e.g. Serine 831 (S-831) and Serine 845 (S-845) on the
GluRl subunit which can be phosphorylated by CaMKII/protein kinase C and protein
kinase A, respectively (Carrol FI et al., 1999). Expression of LTP correlates with a twofold increase in phosphorylation of S-831 and the expression of LTD is correlated with a
decrease in the phosphorylation ofS-845 (Carrol FI et al., 1999). Therefore, knowing the
phosphorylation states the effect they have on LTD/L TP expression may help predict the
state of synaptic plasticity. For example, if LTP is correlated with an increase in
phophorylation of S-831, then removing the phosphate at this particular site may block
LTP expression.
NMDA receptor antagonists inhibit the induction ofboth LTP and LTD that
suggests that NMDA receptors may be an entry point for calcium in the postsynaptic
neuron. This in tum would affect the state of synaptic plasticity (Castellani GC et al.,
2001 ). NMDA receptors are composed of the subunits: NRI and NR2. NR2 subunits
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have four distinct subtypes, 2A-2D, which have specific functions for mediating ionic
currents in the NMDA receptor (Castellani GC et al., 2001). NRl and NR2B subunits
mediate currents at ~ 250 milliseconds whereas NR2A subunit mediates faster currents at
~50

milliseconds (Castellani GC et al., 2001 ). Castellani GC et al. (2001) presented a

model which combines the changes of AMPA receptors with the changes ofNMDA
receptors in order to predict the directionality of synaptic plasticity, LTD or LTP, based
upon the amount of intracellular calcium present within the system being measured. The
combination of particular subunits on glutamate receptors caused modality changes in the
synaptic plasticity. A similar case may be true in the striatum because neurotransmitters
that seem to have a role in synaptic plasticity in the striatum are DA, glutamate and ACh.
These are the neurotransmitters found in the pathway leading from the striosomes > ACh
intemeurons

matrix. However, the interaction of these neurotransmitters and their

on calcium levels in the medium spiny neurons in the striatum has not been
investigated. If their interaction can be shown to affect calcium levels in the striatum,
then it is likely that LTP expression in the striatum could be regulated and as a
consequence LID suppressed.
The imbalance that erupts in the basal ganglia between the DA and glutamate
following DA denervation may contribute to the change in synaptic efficacy in the
striatum (Calabresi P. et al., 2000). Following DA denervation, the striatum experiences
an elevation in both glutamate and ACh (Starr MS, 1995). Both of these
neurotransmitters are modulated by DA (Starr MS, 1995). Thus as DA levels decrease in
the striatum, so does DA's ability to modulate glutamate and ACh. An increase in
glutamate has been proposed to compensate for the depletion of DA in the striatum (Starr
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MS, 1995). The increase in glutamate causes excitation in the striatum whereby the
striatal neurons enter the depolarized state and NMDA receptors are activated. The
NMDA receptor activation allows more calcium to enter the cells for LTP to be
expressed. This disruption of striatal neurotransmitters leads to a difference in synaptic
efficacy in medium spiny neurons that is modulated by an increase in intracellular
calcium levels that results in LTP expression.
Following DA denervation, LTD in the striatum is no longer expressed and
chronic pulsatile administration of levodopa treatment produces LTP in the striatum
(Calabresi P.et al., 2000). Calabresi P. et al. (2000) hypothesizes that after DA
denervation the LTP that is induced by pulsatile levodopa involves a change in gene
expression that leads to altered metabolic functions of postsynaptic striatal neurons
(Figure 10). These altered metabolic functions would ultimately result in apoptosis
(Calabresi P. et al., 2000). Additional alterations noted in Calabresi's (2000)
investigations were changes in NMDA subunits that alter phosphorylation processes and
correlate with LID. Activation of these altered subunits would cause an extensive
elevation in intracellular calcium in striatal spiny neurons, leading to an alteration of the
metabolic state of the cell. These alterations have been thought to promote depolarization
and further NMDA receptor activity in a cyclical manner that is correlated with apoptosis
(Calabresi P. et al., 2000).
Since D2 receptors have a regulating function over glutamate and DA release, the
role of the D2 receptors in regulating synaptic plasticity has been examined. Maura G. et
aL (1988) showed that D2 receptors and possibly D4 (D2 like) receptors are located on
corticostriatal terminals and these receptors inhibit the release of glutamate. Calabresi P.
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et al. ( 1997) compared 02 receptor knock out mice to wild type mice to further
investigate the role of DA receptors in synaptic plasticity. Since HFS has been previously
shown to induce synaptic plasticity in the cerebral cortex, Calabresi P. et al. ( 1997)
decided to use HFS to investigate LTD and L TP in striatal brain slices. In vitro HFS of
brain slices from wild type mice produced LTD, whereas this same stimulation in slices
from D2 receptor deficient mice produced LTP. This seems to suggest that in D2 receptor
deficient mice, either there is a change in synaptic efficacy following repetitive activation
by HFS of corticostriatal projections or that 02 receptors are required for LTD. Freedman
JE and Weight FF (1988) found postsynaptic D2 receptors are capable ofblocking cAMP
activation, activating potassium channels and preventing calcium currents from entering
isolated striatal neurons. This suggests that 02 receptors may be associated with LTD and
in the absence of D2 receptors LTP is expressed in the striatum. Therefore, D2 receptors
could serve to suppress calcium influx in the striatum so that in their absence, calcium
influx occurs and subsequent LTP is produced. Drago J. et al. (1994) reached similar
conclusions during experiments that explored the effects of D 1 and D2 receptor deficient
mice on motor behavior. While Dl receptor deficient mice have normal coordination and
mild hyperactivity (Drago J. et al., 1994), 02 receptor deficient mice present with motor
symptoms of PD (Baik JH et al., 1995 ). These data indicates that D2 receptors play an
instrumental role in long term changes in synaptic efficacy in the striatum and may be
necessary for LTD expression in the striatum.
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Figure 10: (modifiedfrom Calahresi P. et al., 2000) Long Terrn Mechanisms Following
Acute and Chronic Treatment tvith Levodopa. The top half of the diagram depicts DA
dencrvation plus acute levodopa treatment, LTD is produced when striatal neurons are
hyperpolarized (refererred to as "down" state in diagram) and l'ilifDA receptors are
inactive. No LTP is produced during acute levodopa treatment. The bottom half of the
diagram illustrates chronic levodopa treatment post DA denervation. NMDA receptor
activation plus striatal neurons in the depolarized state produce LTP and LID. NJ.,1DA
inactivation and striatal neurons in the hyperpolarized state produces LTD and no LID.
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CHAPTER4
CORRELATIONS BETWEEN MEMORY AND MOTOR PATTERNS IN THE
BASAL GANGLIA AND THE ONSET OF LID

Until very recently, most basal ganglia research has not investigated in depth the
possibility that LID, which greatly compromises the effectiveness ofPD treatments,
could be the result of a memory pattern generated in the basal ganglia. When DA
denervation occurs in PD, the normal continuous flow ofDA to the striatum is
interrupted. At the same time levels of glutan1ate and ACh increase within the striatum.
DA has a modulatory role over both of these neurotransmitters and it is also hypothesized
that the increase in glutamate serves a compensatory role in the striatum when DA levels
decline (Starr MS, 1995). This change in the neurochemistry of the basal ganglia
following DA depletion causes the striatal neurons to transition from a hyperpolarized
state to a depolarized state. As a result of this transition, NMDA receptors on medium
spiny neurons are activated and this fosters an elevation in calcium influx in the medium
spiny neurons ofthe striatum leading to either LTP or LTD. What is not known is to what
degree the interactions among ACh, DA and glutamate regulates intracellular calcium
influx in the medium spiny neurons. In addition, Dl receptor activation in the neurons of
the striosomes and the matrix produces an increase in cAMP production in the medium
spiny neurons of the striatum. The result of ACh interneurons mediated calcium influx
may activate PKC and PKA kinases associated with cAMP responsive-element binding
protein (CREB) transcription changes (Silva et al., 1997). Transcription factors are
nuclear proteins that bind to specific base sequences of DNA in the regulatory regions of
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particular genes so as to regulate their expression. Both the production of cAMP by D l
receptor activation and the increase in calcium can activate CREB transcription factors
(Silva MA et al., 1998). Memory mechanism, in particular, LTP, have been linked to the
activation of CREB transcription factors (Silva MA et al., 1997). Such protein synthesis
and gene expression changes are necessary elements in long term synaptic changes that
are the necessary for long term memory (Silva MA et al., 1997). The molecular changes
that produce long term synaptic changes within the striatum are essentially unknown
(Calon F. et al., 2000). Molecular changes have been observed in the hippocampus during
LTP but there is no conclusive evidence that specific transcription factors produce a form
of long tem1 memory that is manifested as LID in the striatum (Figure 11 ).
The underlying mechanism for the interaction between glutamate and DA in the
striatum is not well understood, but evidence suggests their involvement in cAMP
activation and the identity of sets of genes encoding transcription factors such as CREB
which affect the expression of members of the Fos-Jun family oftranscription factors
(Canales JJ et al., 2002). Expression patterns of immediate early genes (lEG) coding for
the Fos-Jun family of transcription factors are activated during DA-glutamate interaction
in the striatum (Canales JJ et al., 2002). Following DA denervation, the expression of
lEGs changes throughout the course of chronic levodopa treatment and lEG expression
shifts from the matrix region of the striatum to the striosomes (Figure 12).
The shift in IEG expression in the striatum also correlates with the occurrence of
LTD and LTP in the striatum. The cortical inputs to the matrix are innervated by the
association cortex in the medial parts of the striatum and by the sensorimotor cortex in
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the lateral parts of the striatum (Graybiel AM et al., 2000). Cortical inputs to the
striosomes are innervated by the limbic system (Graybiel AM et al., 2000)
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Figure 12: (modified from Graybiel AM et al., 2000). Shift of lEG Expression from
Matrix to Striosomes in Chronic Levodopa Treatment. Shaded areas are activated lEGs
(Fos family) in response to levodopa treatment over time. A) activation of lEG
expression is widespread in the striatum during acute levodopa treatment. B) activation
oflEG expression is predominant in the striosome, as levodopa treatment becomes
chronic and intermittently administered striatal DA is reduced substantially, but some
DA still intact in the striatum. C) activation oflEG expression is found in the striosomes
and in the medial striatum as levodopa treatment becomes chronic and intermittently
administered and the striatal DA has become completely depleted. LID are correlated
with medial striatum/striosome activation (Graybiel eta!., 2000). The dashed lines
indicate areas where LTD is expressed and the bold lines indicate where LTP is
expressed

Acute levodopa treatment correlates with widespread lEG activation in the striatum
(Graybiel AM et al., 2000). As chronic levodopa treatment proceeds over time a
striosome predominant pattern of lEG activation emerges in the anterior and lateral
striatum and LTP is expressed (Graybiel AM et al., 2000). Interestingly, NMDA
glutamate antagonists have been shown to improve LID (Calabresi P.et al., 2000); their
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effectiveness could be a consequence ofblocking the LTP mechanism that may be a
direct result of limiting the calcium influx via NMDA receptors. Blocking the LTP
mechanism in the striatum could then prevent the formation of the motor memories that
constitute LID. Since all the neurotransmitter interactions needed to express striatal LTP
are found in ACh intemeurons, it would be interesting to observe if cholinergic
antagonists also have the potential to block striatal LTP. Indeed, cholinergic antagonists
were the first effective therapeutic agents used to treat PD (Yahr MD, 1993). However,
these anticholinergic treatments were eventually discontinued due to memory
impaim1ents that PD patients encountered. As noted, DA differentially modulates ACh
release through D 1 and D2 receptor stimulation (Calabresi P. et al., 1998). Following the
loss ofDA in PD, ACh modulation is altered resulting in a substantial increase in the
levels of ACh in the striatum. In fact, studies have suggested the oscillatory phase that
striatal neurons present after DA depletion is the result of the increase in ACh which
enables the depolarized state of the striatal neuron and produces LTP in the striatum
(Burgard EC and Sarvey JM, 1990). Thus, by blocking ACh receptors, this may prevent
LTP in the striatum from being formed and, in tum, LID that accompanies chronic
levodopa treatment may potentially be controlled.
Although monoamine mediated heterosynaptic plasticity has been studied in a
number of neural systems, its potential to produce motor memories resulting in LID in
the striatum has not been thoroughly explored. In other neural systems outside the
striatum, the release of monoamine neurotransmitters from one set of synapses can elicit
long term changes in efficacy of transmission in another set of synapses that use a
different neurotransmitter (Schwartz and Greenberg, 1987). In many instances this
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monoamine mediated heterosynaptic plasticity is brought about by the increase in the
intracellular concentration of cAMP (Greenberg SM and Schwartz SH, 1987). In a wide
range of species, these actions of monoamines underlie the storage of memory in the
form of long lasting changes in synaptic efficacy (Greenberg SM and Schwartz SH,
1987). Monoamines mediating the changes in synaptic efficacy in the striatum may be
responsible for the striosomes producing heterosynaptic plasticity in the matrix through
ACh interneurons. The striosomes have a large number of D 1 receptors that are known to
increase cAMP responses. Therefore, levodopa acting in the striosomes synapses on the
ACh interneurons, that in turn, synapse on neurons in the matrix. Since activation of D 1
receptors increases cAMP, the pulsatile administration oflevodopa acting through Dl
receptors in the striosomes may increase cAMP in the cells of the striosomes that, in turn,
activates protein kinases leading to phosphorylation of lEG that activate Fos. Fos/Jun
API complexes induce changes in NMDA receptor expression in the medium spiny
neurons facilitated through ACh interneurons. These NMDA receptor changes would
result in an increase in NMDA receptor activation that would subsequently trigger LTP in
the medium spiny neurons. This example ofheterosynaptic plasticity would yield a
change from LTD to LTP in the medium spiny neurons.
In the striatum, there are several possible sites with an anatomical basis for
heterosynaptic plasticity. The most probable place this heterosynaptic plasticity is taking
place is on medium spiny neurons. Levodopa treatment activates the striosomes that, in
turn, increases cAMP through D 1 receptor activation in the striosomes. The increase in
cAMP activates lEG expression and when coupled with API complexes lead to NMDA
receptor changes in the medium spiny neurons. Indeed medium spiny neurons express
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DA, glutamate and mucarinic receptors and therefore a likely region for heterosynaptic
plasticity to be expressed.
DA denervation results in an increase in glutamate (Starr MS, 1995). Some
investigators have examined the possibility that chronic levodopa treatment further
changes NMDA and AMP A glutamate receptor populations in the striatum, but evidence
has been inconclusive (Starr MS, 1995). Following DA denervation and chronic levodopa
treatment, an increase in tyrosine residue phosphorylation on NMDA subunits which
indicates an increase in NMDA receptor activation and possibly NMDA receptor
concentration has been reported from animal experiments (Menegoz M. et al., 1995).
Similar phosphorylation changes on NMDA subunits have been found during L TP
(Rosemblum K. et al., 1996). It has been noted in postmortem analyses of PD patients
that there is an increase in ligand binding to NMDA receptors suggesting an increase in
glutamate function in the basal ganglia which is correlated with calcium influx and
second messenger cascades (Ulas J. et al., 1994). However, it is not clear whether this
increase in binding ofNMDA receptors is due to the DA depletion or the chronic
levodopa treatment, but pharmacological evidence implies that an abnormal
glutaminergic excitation in the striatum may contribute to the pathophysiology of LID
(Papa SM et al., 1995). When an NMDA receptor antagonist, such as MK 801, is
administered with levodopa to unilaterally 6-hydroxydopaminee lesioned rats, there is a
substantial decrease in motor fluctuations (Papa SM et aL 1995); This effect is
maximized when MK 801 is injected intrastriatally as opposed to systemically or injected
into other regions of the basal ganglia (Marin C. et al., 1996). This suggests that
glutamate acting in the striatum has a major role in inducing LID. Thus, ifNMDA
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antagonists such as MK 801 were administered with levodopa, it might switch the striatal
neurons to a hyperpolarized state and by doing so, induce LTO which is the normal long
term memory mechanism in the striatum (Calabresi P. et al., 2000). Therefore, by
switching the heterosynaptic plasticity to favor LTO over L TP, the objective would be to
minimize LID.
Because of the difficulty assessing new treatments for human diseases,
noninvasive methods such as computer modeling have been employed in recent years in
medical research. By designing an artificial neural network (ANN) to promote a bias in
the modality ofheterosynaptic plasticity in the striatum to favor LTD it may be possible
to limit striatal LTP and thereby control LID which occurs during levodopa treatment in
PD. Because the location of the proposed heterosynaptic mechanism is not certain, an
ANN should assess the neurotransmitters to evaluate the importance of ACh, glutamate
and DA in producing striatal LTP. The effect each of these neurotransmitters has on LTP
expression may provide insight into where the heterosynaptic plasticity is taking place.
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CHAPTERS
ARTIFICIAL NEURAL NETWORKS AS A RESEARCH TOOL IN
PARKINSON'S DISEASE

ANN are sets of algorithms that are modeled after the human brain (Hinton GE,
1992). Generally speaking, they contain mathematical equations that model biological
processes such as learning and memory. Such models representing brain functions
provide an important tool in neuroscience research because they offer a noninvasive
exploration into measuring neuronal function in human pathologies. Neural networks
differ from other types of programming techniques in that they have the unique ability to
learn mathematical relationships between a series of inputs and their corresponding
outputs. For a better understanding of neural network models, Tu JV(l996) provides an
adequate summary. A comparison between ANN and standard statistics is outlined below
in Figure 13. One significant difference between statistics and ANN is the level of
expertise needed in building models.
In a standard statistical format there is a linear relationship between the
independent and dependent variables. The ANN is designed to take complicated
nonlinear relationships and find patterns between the input and output data. These
di ffcrences can be depicted graphically by a diagram of a logistic regression model
(Figure 14) and a basic ANN model (Figure 15). In the past ten years computational
models of PD have begun to be used to complement other investigative methods. Current
researchers have begun to see the importance of neural network modeling as a research
tool in neuropharmacological investigations such as PD and therapeutic dosing
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Figure 13: (modified from Tu JV 1996) Comparative Terms Between ANN and Standard
Statistics
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Figure 14 (modified from Tu JV, 1996) A Basic Logistic Regression Model. Logistic
regression is a commonly used in statistical modeling. The probability of an outcome
relates to a series ofpossible predictor variables. The usual assumption is that these
predictor variables are related in a linear manner. This particular diagram is designed to
predict the probability (p) of a patient dying from a hypothetical disease on the basis of
the age (xi) and sex (x2) of the patient. The values of the beta coefficients are shown.

46

Hidden 1

Input 1
Age (x1)

---.
Output 1

Sex (x2)

•

---J•~ o1

Bias

+exp- -. -.
x -.
h2= 1/(1 +exp-(.37-.65*x1-1.46*x2))
o1 1/(1 +exp-(-.22-.08*h1-1.49*h2))

Bias

Input
layer

Hidden
layer

Output
layer

Figure 15: (modified from Tu JV 1996) A Basic ANN Model. Diagram of an ANN trained
to predict the probability of a patient dying from a hypothetical disease on the basis of
the age ('C l) and sex (x2) of the patient. Each circle represents a node, each line
represents a connection weight. The nodes of the network are in three layers (input,
hidden, output). A logistic activation fimction is used in both the hidden (hl, h2) and
output (01). Hl and h2 are the activation of hidden nodes land 2 and the predicted
output node OJ. At each hidden and output node, a weighted linear combination of the
inputs is summed and then a logistic transformation is applied.

Modeling the neural mechanisms that may be responsible for LID in PD may help to
understand how the basal ganglia interact in healthy versus diseased subjects and may
lead to experimental designs to verify theoretical methods. A variety of plausible
mechanisms of drug action can be examined by designing an ANN system and varying
constraints between neural units. Because ANN are trained rather than programmed, this
leads to further refinement of the model being tested (Tu JV, 1996). Fahn S (1982)
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purported that pathophyiological complications ofPD should be divided into
phannacokinetic and pharmacodynamic mechanisms.
Pharmacokinetic complications relate to problems with absorption and the
metabolism of levodopa (Spencer SE and Wooten GF, 1984). For instance the use of
continuous DA treatment by controlled release capsules helps reduce pharmacokinetic
problems to advanced PO (Chase TN. et al., 1989). However, the pharmacokinetic
aspects alone fail to explain the changes in effectiveness associated with drug therapies
for PD (Fabbrini G. et al., 1987).
Pharmacodynamic complications relate to the variables conditioning the response
ofDA receptors that mediate motor behaviors (Spencer SE and Wooten GF, 1984). An
ANN model ofPD was developed by Jamieson PW et al.(199l) that assessed the effects
oflevodopa pharmacodynamics in PD" Jamieson PW et al. (1991) investigated the
actions ofDA to determine: I) if DA alone was responsible for the LID produced during
chronic treatment oflevodopa 2) how the degree ofDA depletion affects the reactivity in
the striatum 3) if two phannacological mechanisms exist to explain the dyskinetic effects
oflevodopa, and 4) ifboth 01 and 02 receptor types are necessary to produce these
effects. They developed a number of related models to test the system using input units
based on the two necessary components ofLID: degree ofDA depletion and pulsatile
administration of levodopa (Jamieson PW et al., 1991 ). Motor behavior was the output
(Jamieson PW et al., 1991). The models were tested using data from studies ofresponse
fluctuations with levodopa treatment (Mouradian MM, 1988). The results from Jamieson
PW et al. (1991) indicate that the effects of DA depletion and levodopa dose acting on
DA receptors could not solely be responsible for the dyskinetic effects. The most
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consistent data of the Jamieson study was the correlation of increased DA receptor
stimulation to levodopa treatment with increased DA depletion (Jamieson PW et al.,
1991). These results are supported in many experiments that show a greater degree ofDA
denervation correlates with a greater expression of LID (Bertorelli R and Consolo S
1990). The results of the Jamieson study also implied that distinct mechanisms produce
the antiparkinsonian effect of levodopa and LID (Jamieson PW et al., 1991 ).
A more recent study by Wickens J and Kotter R (1998) used a computer model to
explore the striatal mechanisms in PD. This study aimed to clarify some issues that were
not addressed with earlier PD models (Wickens J and Kotter R, 1998). One such issue is
the changes in patterns of neural firing in the basal ganglia that are likely to underlie the
symptoms of PD (Wickens J and Kotter R, 1998). Much of their focus was on dendritic
spines of striatal neurons, regarding them as isolated biological compartments (Wickens J
and Kotter R, 1998). The use of dendritic spines in this manner allowed the researchers to
study the postsynaptic interactions between glutamatergic and dopaminergic afferents in
the striatum (Wickens J and Kotter R, 1998). They noted that following DA depletion,
the morphology of striatal neurons is altered leading to a reduction in the length of
individual spines and a decrease in the overall number of spines (Ingham CA et al.,
1993 ). They hypothesize the change in firing patterns in the striatum is one way to
compensate for the morphological and physiological changes in the basal ganglia that
occur after DA denervation (Wickens J and Kotter R, 1998). Their computer simulations
predict that there is a limit to such compensatory mechanisms in the basal ganglia and
indicate that the effect of levodopa may be to prolong existing bursts in firing patterns in
striatal neurons but not to generate new burst (Wickens J and Kotter R, 1998). Therefore,
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they propose the compensatory mechanisms following DA denervation fail to be
effective when corticostriatal excitation drops below a critical level needed to increase
firing rates in striatal neurons (Wickens J and Kotter R, 1998). This suggests that changes
in firing patterns of striatal neurons induce changes in synaptic plasticity that may alter
the expression in the striatum from LTD to LTP. This has been the case in previously
studied animal models of continuous versus pulsatile levodopa administration where
firing patterns determine whether or not LID developed. These changes in firing patterns
could also correlate with LTD (no LID) and LTP (LID).
A similar study was done by Terman D. et al. (2002), using a computational
network model of activity patterns in the subthalamopallidal circuit of the basal ganglia.
They were particularly interested in assessing the dynamic interaction between STN and
GPe that lead to oscillatory activity patterns within this subthalamopallidal circuit
(Terman D. et al., 2002). They predict that the STN and GPe neurons have traits similar
to those of a central pattern generator and therefore may be able to self-sustain oscillatory
activity. Terman D. et al (2002) followed STN and GPe activity over time in contrast to
most basal ganglia models that are static. Simulations were run to investigate the design
correlating the network with the associated synaptic conductances that may be
modulating the activity of these networks over time (Terman D. et al., 2002). Terman's
models found that this subthalamopallidal circuit is capable of producing both correlated
rhythmic activity and irregular autonomous patterns of activity (Terman D. et al., 2002).
Because neurons in both of these areas have similar membrane properties it was expected
that they would be predisposed to rhythmic firing (Terman D. et al., 2002). Rhythmic
firing refers to correlated patterns between STN and GPe occurring through an elevation
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of striatal input coupled with a decrease of intrapallidal inhibition (Terman D. et al.,
2002). Understanding what causes the change in the circuitry following changes in
striatal input could shed insight into what causes the striatal circuitry change following
DA denervation. An increase in striatal input and weakened intrapallidal inhibition within
the indirect pathway can change the pattern of the circuit from irregular to rhythmic
(Terman D. et al., 2002). The investigators speculate this may be why oscillatory activity
in the subthalamopallidal circuit arises after DA denervation in PD (Terman D. et al.,
2002). This is similar to the matrix circuitry involved in LID which creates an oscillation
of physiological states of striatal neurons following levodopa treatment. This is another
example of a subtle change in basal ganglia circuitry, in this case changes in firing
patterns between GPe and STN, that has a strong influence on the activity of striatal
neurons.
It seem reasonable to suspect the changes in firing patterns that occur after DA

denervation in the striatal neurons is due to the interaction of glutamate and ACh coupled
with levodopa treatment. Pulsatile administration of levodopa activates the striosomal
pathway and therefore produces new signaling patterns in the basal ganglia circuitry
(Graybiel AM et al., 2000). Because the striatum is capable of producing LTD and LTP,
an appropriate neural network model would need to be bimodal in order to account for
the expression of these two synaptic plasticity mechanisms.
A similar model was described in the hippocampus by Huerta and Lisman (1995)
which described a bimodal heterosynaptic plasticity induced during cholinergic
oscillation in vitro. The frequency of synaptic stimulation appears to determine whether
CAl synapses express LTD or LTP (Huerta PT and Lisman JE, 1995). The investigators
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found that cholinergic oscillatory bursts were responsible for inducing LTP or LTD in the
CAl area ofthe hippocampus (Huerta PT and Lisman JE, 1995). The cholinergic system
originating in the medial septum innervates the whole hippocampus and is known to
enhance synaptic plasticity (Huerta PT and Lisman JE, 1995). Studies have shown that
low doses of cholinergic agonists produce a slight enhancement of LTP in the
hippocampus whereas high doses of cholinergic agonists produce a network oscillation
(Burgard EC and Sarvey JM, 1990). Following DA denervation, there is an elevation of
ACh in the striatum that may be responsible for LTP expression in the striatum in a
manner similar to that observed in Huerta and Lisman's study. Huerta PT and Lisman
JE( 1995) looked specifically at the type of synaptic plasticity produced during very brief
bursts of stimulation in the hippocampus (4 shocks at lOO Hz) in vitro. Previous studies
had suggested the frequency of synaptic stimulation determines whether LTD or LTP is
produced (Artola A and Singer W, 1993; Teyler TJ et al., 1994). The results of Huerta PT
and Lisman JE (1995) showed that during the cholinergic oscillations the timing of the
stimulation relative to the oscillation phase predicted the type of synaptic plasticity,
which determined whether LTD or LTP was expressed (Huerta PT and Lisman JE, 1995).
For instance when excitatory postsynaptic potentials (EPSP) spikes were plotted over
time they found LTP was expressed when these cholinergic oscillations were at the peak
and LTD when they were at their trough (Huerta PT and Lisman JE, 1995). This suggests
a correlation between excitatory stimulation and LTP and this excitation may be directly
proportional to calcium influx. During the network oscillation, CAl neurons ofthe
hippocampus display subthreshold and suprathreshold oscillations, with amplitudes of 525 mV (Leung LS and Yim CY, 1986; MacVicar BA and Tse FW, 1989). Such
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postsynaptic voltage fluctuations could influence plasticity by increasing stimulation
intensity. The oscillating behavior itself is induced by cholinergic action and in its
absence synaptic plasticity is greatly reduced (Huerta PT and Lisman JE, 1995). This
suggests ACh plays a strong role in synaptic plasticity. In addition, cholinergic
innervation is able to depolarize pyramidal neurons by blocking potassium channels that
reduces calcium influx inhibition (Huerta PT and Lisman JE, 1995). Therefore, the study
by Huerta PT and Lisman JE ( 1995) supports the idea that ACh intemeurons have a
strong role in heterosynaptic plasticity in the hippocampus. It is reasonable to suggest that
a similar mechanism may be taking place in the striatum since the anatomical
arrangement that allows heterosynaptic plasticity in the striatum has the potential for
bimodal synaptic modification: LTD and LTP. By designing a network that represents the
neurotransmitters involved in striatal heterosynaptic plasticity that would produce LTO
and inhibit LTP, a network model for controlling LID may lay the foundation for future
experimental analysis.
A bidirectional neural network was modeled by Wakuya Hand Zurada JM (2001)
in tracking sun spot data. The beauty of this model is that it has the ability to portray two
subnetworks performing two types of signal transfonnations bidirectionally. In this
model it takes past information and compares it to new input infomution. For systems
that rely on past information to predict future outcomes, this model is particularly useful
(Figure 16). In addition, the subnetworks receive complementary signals through mutual
connections (Wakuya Hand Zurada JM, 2001).
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Figure 16 (modified from Wakuya Hand Zurada JM, 2001). Bidirectional ANN Model
Based Upon Past and Present Values to Predict Future Values. Outline of the signal flow
within the bidirectional computing structure. In this figure, the upper half deals with the
fitture prediction task, a transformation from the present signal to the future signal. The
lower half deals with the past prediction task, a transformation from the desired fi-tture
signals to the present signal. These two transformations cooperate with each other
through their mutual connections.

Such a model seems appropriate for illustrating the heterosynaptic bimodal
synaptic plasticity in the striatum. The bimodality illustrates the ability of the striatal
medium spiny neurons to oscillate towards a depolarized or hyperpolarized state and
depicts the synaptic plasticity correlated with these states. The depolarized state has been
associated with LTP, a mechanism induced by DA administration following DA
denervation (Calabresi P. et al., 1999). The optimal neural network design would then
seem to be one that used DA agonist, glutamate antagonists and ACh antagonist as input
components and trained the network by varying their concentrations and effects on
synaptic plasticity based on one particular neurotransmitter (e.g. ACh, DA or glutamate),
while assessing their collaborative effects. The goal would be to determine which
54

combinations produce the output (LTD) and which produce the output (LTP). An
illustration of such an ANN of bimodal heterosynaptic plasticity in the striatum similar to
the bidirectional model used by Wakuya H. and Zurada JM is depicted in Figure 17.
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Figure 17: ANN Model of Bimodal Heterosvnaptic Mechanism in the Striatum. The upper
half of the diagram shows chronic levodopa that leads to LTP and LID, the bottom half
illustrates the hJpothesis that ACh and/or glutamate antagonists may inhibit LTPILID
and produce LTD. The middle components, LTD and LTP, represent the fact these two
states oF'>:vnaptic plasticity are flexible and exist in an extended continuum based upon
the amount of calcium in the system.

If the model predicts that activation of certain combinations of neurotransmitters
produces LTD along with the simultaneous inhibition of LTP, it may be advantageous to
further investigate the results by a laboratory experiment to verify the neural network
model. Confirmation of this model may lay the groundwork for improved
pharmacological intervention in the treatment of PD. [t has been observed that following
DA denervation, changes in striatal levels of ACh and glutamate are observed. Both
glutamate and ACh interact and are modulated by DA. Both LTD and LTP depend upon

55

DA and glutamate in the striatum. However, the role of ACh in producing either of these
two long term mechanisms, L TP and LTO, has not been thoroughly addressed. These
three neurotransmitters: DA, glutamate and ACh need to be assessed individually first,
followed by the effects of their interaction to see how they might direct the
heterosynaptic plasticity towards LTO or LTP.
A similar design was modeled by Castellani GC et al. (200 1). Researchers looked
at bidirectional synaptic plasticity in the mammalian cortex and its dependence on AMP A
and NMDA receptors. Their model denoted the particular states of LTD and LTP as a
function of calcium concentration (Castellani GC et al., 2001). Their model claims that
by knowing the local postsynaptic concentration of intracellular calcium one may deduce
the status ofNMDA receptor subunit phosphorylation and thus synaptic efficacy. They
conclude that changes in the number and/or subunit composition ofNMDA glutamate
receptors in the postsynaptic membrane determine the calcium concentration and
therefore LTD or LTP (Castellani GC et al., 2001). Phosphorylation sites on NMDA and
AMP A receptors can therefore serve as a predictor of a change in the direction of
synaptic strengthening or weakening (Figure 18) (Castellani GC et al., 2001 ).
Clearly ANN have a useful place in scientific research. As mentioned ANN can
be designed with less formal training than in standard statistical modeling and offer
superior assessment of nonlinear relationships. ANN are limited in their
oversimplification of biological processes but remain a good starting point for assessing
variables and laying the foundation for laboratory experimentation. A few negative facts
to note about ANN are their limitations in validating causal relationships (Tu JV, 1996).
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Figure 18: (modified from Castellani GC eta!., 200 I) Direction of Plasticity: LTD or
LTP Depends Upon Phosphorylation Sites. Phosphorylation sites influence the amount of
calcium present at the AivtPA receptors (from Castellani et a/.,2001). A model ofGlu Rl
phosphorylation/dephosphorylation at two sites. The model assumes tlvo specific kinases
(kinase!, kinase2) and two opposing specific phosphatases {phosphatase]
,plwsphatase2). Presumably, high frequency stimulation preferentially stimulates the
activit}' ofprotein kinases resulting in GluRI phosphorylation. Low frequency stimulation
preferentially stimulates the activity ofprotein phosphatases resulting in GluR I
dephosphotylation

In other words, it is often difficult to be certain of the deeper relationships that may be
hidden in the data or conversely, relationships may appear to exist on the surface but may
just be false positives. In this respect, logistical models from standard statistics are far
better at and often focus on inferring causal relationships (Tu JV, 1996). In logistic
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regression, variables may be determined which are the strongest predictors of outcomes
based on odds ratio and beta-coefficients (Tu JV, 1996). In addition, in a stepwise
manner, independent variables may be eliminated if they are not correlated to a particular
outcome (Tu JV, 1996). In an ANN, the training data are fed into the system and the
network trains itselfby finding the input variables that produces a particular outcome (Tu
JV, 1996). In this arrangement, insignificant predictor variables may not be recognized
since no reliable criteria exist for interpreting weights in a connection weight matrix (Tu
JV, 1996). The intent ofthe ANN for the LID model may be at a significant disadvantage
because relationships between neurotransmitters and their respective agonists and
antagonists may show a correlation with LTP without being mechanistically linked.
However, these relationships could be verified through laboratory experimentation.
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CHAPTER6
FACTORS IN ASSESSING STRIATAL HETEROSYNAPTIC LTP PLASTICITY

DA and ACh

Although many studies have been conducted that examines the relationship
between DA and glutamate and other studies have probed the relationship between DA
and ACh, little research exists that has combined the interaction of all three of these
neurochemicals and their effects on LID. In recent years, researchers have verified the
significance of both pulsatile administration of DA in the DA denervated system and an
increase in glutamate in producing striatal LTP over LTD (Calabresi P. et al., 1997).
However, the role of ACh in striatal LTD and LTP have not been clearly defined. It is
thought that DA, glutamate and ACh interactions may produce LID as a possible result of
inducing LTP in the striatum. By designing a neural network that will combine aspects of
research data including: levodopa levels, ACh antagonist levels, glutamate antagonist
levels, and their effects on inhibiting LTP, possible insight into controlling striatal LID
may result. Such correlations would allow laboratory experimentations to further
investigate this hypothesis. In designing this model, it may be advantageous to review
what is known about each independent variable first, then decide on the best design to
assess the variable DA-ACh-glutamate interactions.
Initial observations ofthe interactions between DA and ACh in the
extrapyramidal system were based upon clinical investigations ofPD patients in the early
1960s (Lehman 1 and Langer SZ, 1983). Muscarinic receptor antagonists that decrease
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cholinergic function, relieve PD symptoms in a manner similar to DA agonists (Lehman J
and Langer SZ, 1983). Therefore it was proposed by researchers that the endogenous
neurotransmitters, DA and ACh, had opposite functions in the extrapyramidal system
(Lehman J and Langer SZ, 1983 ). It was soon postulated that under normal conditions,
ACh and DA are in a state ofbalance (Barbeau A, 1962).
TheDA and ACh interaction is also observed in biochemical studies of
neurotransmitter turnover. Administering DA receptor agonists produces a decrease in
ACh turnover in the striatum (Lehman J and Langer SZ, 1983). In response to DA
receptor agonist, apomorphine, there is a decrease in ACh release and turnover in the
intact system. The first model to explain the DA and ACh interactions emerged in the
1970s which claimed DA terminals in the striatum form inhibitory connections on the
dendrites of the striatal cholinergic interneurons. This allowed DA receptor stimulation to
inhibit the activity of cholinergic interneurons by acting as a link between DA terminals
and other interneurons or to efferent neurons in the striatum (Lehman J and Langer SZ,
1983). This would allow ACh interneurons to act as a trans-synaptic "second-messenger"
of DA receptor stimulation. However, anatomical and pharmacological data conflicted
with the idea that ACh dendrites were the exclusive or even most abundant postsynaptic
target ofDA terminals (Lehman J and Langer SZ, 1983). Thus, although a relationship
between DA and ACh exists, the details of this interaction appear to be more elusive.
Huerta PT and Lisman JE (1993) found cholinergic agonists depolarized striatal
neurons by blocking potassium channels. The depolarization of striatal neurons is also a
factor in eliciting striatal LTP. As noted earlier, striatal neurons are usually at a low level
of excitation and express LTD due to the numerous open potassium channels that
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counteract the influx of calcium. Therefore blocking ACh receptors may be one factor
affecting striatal LTP formation following DA denervation and levodopa treatment
systems. Other evidence suggests muscarinic receptor activation has a role in stabilizing
striatal transition states (Suzuki T. et al., 1998). While the majority of cholinergic
intemeurons are located in the matrix of the striatum, their neurites extend into the
striosomes and therefore could serve as a link between these two striatal compartments
(Blanchet F. et al., 1997). The density of cholinergic intemeurons is about two fold
higher along the matrix/striosome border compared to regions outside of this border
(Blanchet

et al., 1997). Thus, ACh seems to be ideally positioned to serve in the

heterosynaptic plasticity between the striosomes and the matrix.

DA and Glutamate

Studies have shown both DA and glutamate are necessary elements for LTD and
LTP expression (Calabresi P. et al., 1997). DA denervation is accompanied by an
increase in glutamate that affects the striatal physiological states of neurons. Following
chronic levodopa treatment LTP is expressed over LTD. NMDA and AMPA receptors
are located on ACh intemeurons and medium spiny neurons in the matrix of the striatum
(Calabresi P. et al., 1999). Scientists have found a relationship between NMDA receptor
activation on medium spiny neurons and LTP expression in these same neurons in DA
denervated systems treated with levodopa (Calabresi P. et al., 1999). Following DA
denervation, there is an increase in striatal levels of ACh and glutamate (Starr MS, 1995).
Such excitatory chemical input could alter physiological striatal states. Interestingly,
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Gubellini P. et al. (1997) found that endogenously produced ACh enhanced NMDA
responses, which increased protein kinase C (PKC) activation in medium spiny neurons.
This suggests a possible role of ACh inducing a long lasting elevation of corticostriatal
glutamatergic transmission (Gubellini P. et al., 1997). Studies have shown that the
increase in ACh may allow for more binding of glutamate at NMDA receptors (Gubellini
P. et al., 1997). They also documented that glutamate binding to NMDA receptors
stimulates the release of ACh in striatal compartments indicating that there seems to be
some role of positive feedback and/or coupling between ACh and glutamate following
DA denervation (Blanchet F. et al., 1997).
Bimodal regulation of synaptic strength has been hypothesized to depend on
changes in the number and/or the composition ofNMDA and AMPA glutamate receptor
subunits. Glutamate receptors' function is regulated by their subunit composition on
individual receptors and/or the phosphorylation/dephosphorylation state of individual
subunits. Therefore, knowledge ofthe phosphorylation states of AMPA subunits and
NMDA subunits may be a strong predictor of the modality change (increase/decrease) of
calcium influx and therefore whether LTD or LTP is induced.

62

CHAPTER 7
CONCLUDING REMARKS

Among the flaws in the current basal ganglia model are that it does not take into
account the anatomical and functional differences between the neurons in the matrix and
in the striosomes of the striatum nor the possibility of their influence upon one another.
Although most basal ganglia research has independently focused on their control of
movement and their role in memory and learning, very few researchers have drawn
correlations between these two lines of study. The possibility that the striosomal pathway
may influence the direct and indirect striatal pathways of the matrix can be assessed on
two levels. First, the striosomal pathway projects to the SNc that gives rise to the
nigrostriatal pathway (Starr MS, 1995). Therefore, a cooperative system may exist in the
striatum not simply between the direct and indirect pathways, but between the striosomal
pathway and the matrix as well. It is possible that the striosomal pathway may serve to
regulate or evaluate incoming signals to the nigrostriatal pathway through a
heterosynaptic mechanism and once the neurotransmitter systems (i.e. DA and glutamate)
are disrupted in PD, the control of input signals into the striatum is reduced. Secondly,
lining the border between the striosomes and matrix are ACh intemeurons (Pollack AE,
2001; Starr MS, 1995). These ACh intemeurons are in the position to relay information
from the striosomal pathway to the direct and indirect pathways of the matrix through a
heterosynaptic mechanism. The information communicated from the striosomes to the
matrix may elicit protein changes in the medium spiny neurons of the cells ofthe striatal
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matrix. These protein changes may contribute to NMDA receptor activation and
increased calcium influx. Therefore a bimodality in the heterosynaptic mechanism may
explain the differences in responses to continuous versus intermittent levodopa
administration eliciting either LTD or L TP in the striatum.
A disruption in the balance between DA and glutamate interaction in the striatum
develops following DA denervation and subsequent levodopa treatment. It is not known
to what extent ACh functions to modulate the concentrations ofDA, glutamate and
calcium in the striatum, but clearly ACh plays a role since NMDA and AMPA receptors
are found on ACh intemeurons in the striatum (Calabresi P. et al., 1995). In addition,
following DA denervation, striatal neurons, usually in a hyperpolarized state, transition
into an oscillatory state, changing from a hyperpolarized to a depolarized state (Calabresi
P. et al., 2000). This oscillatory behavior is not caused by intrinsic membrane properties,
but is the result ofDA denervation and the release of glutamate from cortical neurons
(Calabresi P. et al., 2000). Just as oscillatory neuronal states are not typical for the intact
and normal functioning striatum, LTP is not typically the mechanism expressed in the
striatum; under nom1al circumstances, the striatum typically expresses LTD and
following DA denervation and levodopa treatment, LTP is produced in the striatum
(Calabresi P. et al., 2000).
In many regions of the brain, including the cortex, the magnitude and sign of
activity dependent changes in synaptic strength depend on the presynaptic frequency of
firing as well as the history of activity at those synapses (Castellani GC et al., 2001 ). By
comparing different dosages oflevodopa, ACh and glutamate antagonists and by
assessing the relationship ofthese three neurotransmitters in a bimodal neural network
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system, manipulation of LTD over LTP may be achieved. In the model designed for
assessing the interactions among ACh, glutamate and DA, each ofthese
neurotransmitters will be used as an input into the system (Figure 19). Various doses of
levodopa, ACh and glutamate antagonists for each of these transmitters will be given to
act on each variable independently as well as simultaneously. The system will be trained
to produce the output LTD and inhibit the output LTP formation by adjustment ofthe
input variables ACh, glutamate and DA.
Necessary elements for building a neural network for therapeutic doing of PD
would include a collection of data of the variables described above. The immediate object
is to decrease the excitability and thus, the depolarized state of striatal neurons that will
further block excitation via NMDA receptor stimulation, thereby, preventing LTP. It is
not known which variables: levodopa levels, ACh antagonist levels or glutamate
antagonist levels or if a combination of variables will be the most successful in
preventing LTP and producing LTD in the neural network model. . The long-term
mechanisms (i.e. LTD and LTP) can be directed either way depending on the variables
and their nonlinear relationship. An expanded version of a bidirectional/bimodal model is
found in Zurada JM ( 1992) (Figure 20).
A condensed and simplified version of this bi-directional/bimodal model is
illustrated (Figure 21 ). The fundamental structures of Figure 20 and Figure 21 are based
upon Zurada's (1992) bidirectional/bimodal associative memory ANN that uses
stimulus/response association to produce output. Details are found in the Appendix.
Current and past research has studied the independent effects of anticholinergics
and glutamate antagonists on rotational behavior in animal experiments as well as clinical
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treatments to decrease LID in PD patients. The reasons why these treatments are effective
in decreasing LID have not been understood. Ifthese variables: levodopa levels, ACh
antagonist levels and glutamate antagonist levels either acting independently or
interacting together control calcium influx in the striatum, this would prevent LTP. No
such experiments have been found in recent literature. However, anticholinergics are
known to have very severe side effects on memory. Chemical agents that alter
phosphorylation of AMP A subunits may be one alternative to anticholinergics and
general NMDA antagonist since increased phosphorylation of AMPA receptors has a
direct inverse relationship with calcium influx (Castellani GC et al., 2001). Thus, at
higher levels of AMP A subunit phosphorylation there is a lowering of intracellular
calcium concentration and less chance for LTP to develop (Castellani GC et al., 2001 ).
Although the ANN presented in this thesis does not focus on this issue, potential
experiments may want to address this issue.
Many computational models have been designed to study the dynamics of PD.
Such idealized models form a solid foundation for laboratory experimentation. Thus, the
ultimate goal of designing an ANN model to produce LTD and inhibit LTP would be to
test therapeutic dosing regiments in a laboratory environment in hopes of offering novel
treatments for PD patients. Since independent variables that will produce the most
effective LTP suppression have not been assessed, the computational model will be an
efficient tool in unveiling these variables.
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Figure 19: Inputs and Nonlinear Assessment to the LTD Ouput: Interactions amongst the
inputs: levodopa, ACh antagonist and glutamate antagonist combine to yield LTD. This is
accomplished by minimizing calcium levels and thereby suppressing LTP formation in
the striatum. The nonlinear interactions take place in the hidden layer and the
combinations that yield LTD will be produced as the output.
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Layer B

Layer A

Figure 20: (modified from Zurada, 1992). Expanded Bidirectional ANN Model (from
Zurada, 1992). A bidirectional neural network uses the forward and backward
information flow to produce an associative search for stored stimulus-response
association
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>ca2+
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<
Figure 21: Bimodal ANN Model ofLTD-LTP in the Striatum. The appropriate
combination oflevodopa, ACh antagonist and glutamate antagonist will produce either
LTP or LTD in the striatum. An output that generates an elevation in calcium will
produce LTP and an output that generates a relative inhibition of calcium will produce
LTD.
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To date, treatment for PD with levodopa has retained a compromised clinical
benefit. The worst and most disabling side effect consists of LID that almost always
appears after chronic levodopa treatments. If the hypothesis that LID are a manifestation
of LTP in the striatum is correct, then new avenues of treatment for PD will follow.
Alternative therapies will be explored that offer less side effects compared to the current
standard treatments that produce LID and compromise PD patients' standard of living
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APPENDIX

Zurada's (1992) bidirectional/bimodal associative memory ANN that uses
stimulus/response association to produce output.

eq. 1

These sets are association pairs that are stored in the memory model. If the
memory neurons are activated, the network dynamics correlates two layers of interaction.
Refer once again to Figure 16. Assume an initializing vector b at the input to the layer A
L TP. This input will be processed through the

of neurons. In the assumption, layer A
hidden layer as follows:

a'

f[Wb]

eq.2

This equation is a nonlinear operator. It involves matrix multiplication. If layer A
=

LTP, layer B =LTD

a~ = sgn ( ~ W··b)
I

."-'

yl

I)

}

fori = 1, 2, ... , n

'

eq.3
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Vector a' feeds the layer B, LTD, of neurons. If the transposed matrix is used, W'
of layer B, we find:

eq.4
Again, matrix multiplication processes the information:

bj = sgn

(.f wua;),

for j

=

1, 2, ... , m

i=l

eq. 5

This sequence will be repeated to compute a', b', and so on ... The process
continues as information is received. Once data is no longer being updated, the a & b
functions will stop. It is a recursive update mechanism consisting ofthe following steps:

First Backward Pass:

a 1 = f[Wb 0 ]
b 2 = f[Wra 1]

Second Forward Pass:

a 3 = f[Wb 2 ]

First Forward Pass:

k/2'th Backward Pass:
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The back and forth nature of the flow, aims to equilibrate in one of the fixed pairs from
eq. 1.
It should be noted, in this particular memory model, that an assumption is made
that no state changes are occurring in layers A and B at the same time. Data must flow in
a circular fashion. In other words, one cannot simultaneously be at output A and output
B. This makes sense in the LTP/L TD model. The direction of flow in the LTP/LTD

depends on the level of calcium, the type of glutamate receptor activated and the DA
pulsatile activation encountered.
Once data is processed it is coded into the bidirectional/bimodal associative
memory usually by the outer product rule, or simply by adding p cross-correlation
matrices (Zurada, 1992). The weight matrix formula is:

W

f

=

a<i)b(i)r

i=l

eq.6

[n eq. 6, a(i) and b(i) are members of the ith pair and are equivalent to the
Hebbian learning rule which yields the following weight values:

W··
lJ

=

p

~ a~m)b~m)
£...
l
J
m=l

73

eq. 7

If a stored pattern, a/\(m/\t) is presented to this memory, the retrieval process
follows from eq.5:

eq. 8
This further reduces to:

b

=

r [nb(m') +

f

b(m)a(m)ta(m')]

m'i=m'

eq.9
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